Patents by Inventor Stephen L. Nutt
Stephen L. Nutt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7071306Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR4B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.Type: GrantFiled: April 15, 2002Date of Patent: July 4, 2006Assignee: NPS Allelix Corp.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 7030221Abstract: Described herein are isolated polynucleotides which code for a family of AMPA-type human CNS receptors. The receptors are characterized structurally and the construction and use of cell lines expressing these receptors are disclosed.Type: GrantFiled: May 21, 2002Date of Patent: April 18, 2006Assignee: NPS Allelix Corp.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Publication number: 20030053993Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR4B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.Type: ApplicationFiled: April 15, 2002Publication date: March 20, 2003Applicant: NPS ALLELIX CORP.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Publication number: 20030032038Abstract: Described herein are isolated polynucleotides which code for a family of AMPA-type human CNS receptors. The receptors are characterized structurally and the construction and use of cell lines expressing these receptors are disclosed.Type: ApplicationFiled: May 21, 2002Publication date: February 13, 2003Applicant: NPS Allelix CorporatonInventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6500624Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of the kainate-binding type of EAA receptor, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.Type: GrantFiled: February 1, 1994Date of Patent: December 31, 2002Assignee: NPS Allelix Corp.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Publication number: 20020168723Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of these receptors of the kainate-binding type of EAA receptors, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.Type: ApplicationFiled: April 22, 2002Publication date: November 14, 2002Applicant: NPS Allelix Corp.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6441155Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR2B receptor. The receptor is charactereized structurally and the construction and use of cell lines expressing these receptor is disclosed.Type: GrantFiled: May 13, 1994Date of Patent: August 27, 2002Assignee: NPS Allelix Corp.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6413739Abstract: Described herein are isolated polynucleotides which code for a family of AMPA-type human CNS receptors. The receptors are characterized structurally and the construction and use of cell lines expressing these receptors are disclosed.Type: GrantFiled: July 17, 1997Date of Patent: July 2, 2002Assignee: NPS Allelix Corp.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6406868Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR1B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.Type: GrantFiled: March 23, 1994Date of Patent: June 18, 2002Assignee: NPS Allelix CorporationInventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6403323Abstract: Described herein are isolated polynucleotides which code for a family of AMPA-type human CNS receptors. The receptors are characterized structurally and the construction and use of cell lines expressing these receptors are disclosed.Type: GrantFiled: June 8, 1994Date of Patent: June 11, 2002Assignee: NPS Allelix CorporationInventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6399313Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR2B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing these receptor is disclosed.Type: GrantFiled: May 12, 1995Date of Patent: June 4, 2002Assignee: NPS Allelix Corp.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6376200Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of these receptors of the kainate-binding type of EAA receptors, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.Type: GrantFiled: May 25, 1994Date of Patent: April 23, 2002Assignee: NPS Alleix Corp.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6372488Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR4B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.Type: GrantFiled: June 7, 1995Date of Patent: April 16, 2002Assignee: NPS Allelix Corp.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6358693Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR4B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.Type: GrantFiled: March 14, 1995Date of Patent: March 19, 2002Assignee: NPS Allelix Corp.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6333161Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of these receptors of the kainate-binding type of EAA receptors, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.Type: GrantFiled: January 6, 1994Date of Patent: December 25, 2001Assignee: NPS Allelix CorporationInventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6322999Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of these receptors of the kainate-binding type of EAA receptors, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.Type: GrantFiled: January 24, 1995Date of Patent: November 27, 2001Assignee: NPS Allelix Corp.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6040175Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS glutamate receptor, designated the human GluR2B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing these receptor is disclosed.Type: GrantFiled: June 7, 1995Date of Patent: March 21, 2000Assignee: Allelix Biopharmaceuticals, Inc.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6018023Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of the kainate-binding type of EAA receptor, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.Type: GrantFiled: June 7, 1995Date of Patent: January 25, 2000Assignee: Allelix Biopharmaceuticals Inc.Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
-
Patent number: 6013768Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of these receptors, of the kainate binding type of EAA receptors, has now been isolated and the receptor protein characterized. Herein described art recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.Type: GrantFiled: January 27, 1997Date of Patent: January 11, 2000Assignee: Allelix Biopharmaceuticals, Inc.Inventors: Rajender Kamboj, Stephen L. Nutt, Lee Shekter, Michael A. Wosnick
-
Patent number: 5981704Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of these receptors, of the kainate binding type of EAA receptors, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor simulation.Type: GrantFiled: March 20, 1997Date of Patent: November 9, 1999Assignee: Allelix BiopharmaceuticalInventors: Rajender Kamboj, Stephen L. Nutt, Lee Shekter, Michael A. Wosnick